Effectiveness of hospital-based oral dextrose gel in prevention and treatment of asymptomatic newborns at risk of hypoglycemia

References

• Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J. Pediatr. 2012;161(5):1–8. doi: 10.1016/j.jpeds.2012.05.022.
   PubMed Web of Science ®Google Scholar
• Thompson-Branch A, Havranek T. Neonatal hypoglycemia. Pediatr Rev. 2017;38(4):147–157. doi: 10.1542/pir.2016-0063.
   PubMed Web of Science ®Google Scholar
• Adamkin DH,. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127(3):575–579. doi: 10.1542/peds.2010-3851.
   PubMed Web of Science ®Google Scholar
• Vain NE, Chiarelli F. Neonatal hypoglycaemia: a never-ending story? Neonatology. 2021;118(5):522–529. doi: 10.1159/000514711.
   PubMed Web of Science ®Google Scholar
• McKinlay CJ, Alsweiler JM, Ansell JM, et al. Neonatal glycemia and neurodevelopmental outcomes at 2 years. N Engl J Med. 2015;373(16):1507–1518. doi: 10.1056/NEJMoa1504909.
   PubMed Web of Science ®Google Scholar
• McKinlay CJD, Alsweiler JM, Anstice NS, et al. Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr. 2017;171(10):972–983. doi: 10.1001/jamapediatrics.2017.1579.
   PubMed Web of Science ®Google Scholar
• Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J. Pediatr. 2015;167(2):238–245. doi: 10.1016/j.jpeds.2015.03.057.
   PubMed Web of Science ®Google Scholar
• Canadian Paediatric Society. Screening guidelines for newborns at risk for low blood glucose. Paediatr. Child Health. 2004;9(10):723–729. doi: 10.1093/pch/9.10.723.
   PubMedGoogle Scholar
• Roberts L, Lin L, Alsweiler J, et al. Oral dextrose gel to prevent hypoglycaemia in at-risk neonates. Cochrane Database Syst Rev. 2023;11(11):CD012152. doi: 10.1002/14651858.CD012152.pub4.
   PubMedGoogle Scholar
• Edwards T, Liu G, Battin M, et al. Oral dextrose gel for the treatment of hypoglycaemia in newborn infants. Cochrane Database Syst. Rev. 2022;3(3):CD011027. doi: 10.1002/14651858.CD011027.pub3.
   PubMedGoogle Scholar
• Harris DL, Weston PJ, Signal M, et al. Dextrose gel for neonatal hypoglycaemia (the sugar babies study): a randomised, double-blind, placebo-controlled trial. Lancet. 2013;382(9910):2077–2083. doi: 10.1016/S0140-6736(13)61645-1.
   PubMed Web of Science ®Google Scholar
• Hegarty JE, Harding JE, Gamble GD, et al. Prophylactic oral dextrose gel for newborn babies at risk of neonatal hypoglycaemia: a randomised controlled dose-finding trial (the pre-hPOD study). PLOS Med. 2016;13(10):e1002155. doi: 10.1371/journal.pmed.1002155.
   PubMed Web of Science ®Google Scholar
• Rawat M, Chandrasekharan P, Turkovich S, et al. Oral dextrose gel reduces the need for intravenous dextrose therapy in neonatal hypoglycemia. Biomed Hub. 2016;1(3):1–9. doi: 10.1159/000448511.
   PubMedGoogle Scholar
• Ter M, Halibullah I, Leung L, et al. Implementation of dextrose gel in the management of neonatal hypoglycaemia. J Paediatrics Child Health. 2017;53(4):408–411. doi: 10.1111/jpc.13409.
   PubMed Web of Science ®Google Scholar
• Makker K, Alissa R, Dudek C, et al. Glucose gel in infants at risk for transitional neonatal hypoglycemia. Am. J. Perinatol. 2018;35(11):1050–1056. doi: 10.1055/s-0038-1639338.
   PubMed Web of Science ®Google Scholar
• Glasgow MJ, Harding JE, Edlin R,. Cost analysis of treating neonatal hypoglycemia with dextrose gel. J Pediatr. 2018;198:151–155. e1. doi: 10.1016/j.jpeds.2018.02.036.
   PubMed Web of Science ®Google Scholar
• Newnam KM, Bunch M. Glucose gel as a treatment strategy for transient neonatal hypoglycemia. Adv. Neonatal Care. 2017;17(6):470–477. doi: 10.1097/ANC.0000000000000426.
   PubMed Web of Science ®Google Scholar
• Meneghin F, Manzalini M, Acunzo M, et al. Management of asymptomatic hypoglycemia with 40% oral dextrose gel in near term at-risk infants to reduce intensive care need and promote breastfeeding. Ital J Pediatr. 2021;47(1):201. doi: 10.1186/s13052-021-01149-7.
   PubMed Web of Science ®Google Scholar
• Gibson BL, Carter BM, LeDuff LD, 3rd, et al. 40% Glucose gel for the treatment of asymptomatic neonatal hypoglycemia. Adv. Neonatal Care. 2021;21(5):371–378. doi: 10.1097/ANC.0000000000000823.
   PubMed Web of Science ®Google Scholar
• Desai P, Verma S, Bhargava S, et al. Implementation and outcomes of a standard dose dextrose gel protocol for management of transient neonatal hypoglycemia. J Perinatol. 2022;42(8):1097–1102. doi: 10.1038/s41372-021-01284-3.
   PubMed Web of Science ®Google Scholar
• Gupta K, Amboiram P, Balakrishnan U, et al. Dextrose gel for neonates at risk with asymptomatic hypoglycemia: a randomized clinical trial. Pediatrics. 2022;149(6):e2021050733. doi: 10.1542/peds.2021-050733.
   PubMed Web of Science ®Google Scholar
• Parappil H, Gaffari M, Ahmed J, et al. Oral dextrose gel use in asymptomatic hypoglycemic newborns decreases NICU admissions and parenteral dextrose therapy: a retrospective study. NPM. 2023;16(1):111–117. doi: 10.3233/NPM-221170.
   Google Scholar
• Gregory K, Turner D, Benjamin CN, et al. Incorporating dextrose gel and feeding in the treatment of neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed. 2020;105(1):45–49. doi: 10.1136/archdischild-2018-316430.
   PubMed Web of Science ®Google Scholar
• Sen S, Andrews C, Anderson E, et al. Type of feeding provided with dextrose gel impacts hypoglycemia outcomes: comparing donor milk, formula, and breastfeeding. J Perinatol. 2020;40(11):1705–1711. doi: 10.1038/s41372-020-00776-y.
   PubMed Web of Science ®Google Scholar